InvestorsHub Logo
Followers 1
Posts 426
Boards Moderated 0
Alias Born 06/10/2018

Re: None

Thursday, 07/06/2023 7:11:35 AM

Thursday, July 06, 2023 7:11:35 AM

Post# of 1530
Immune Pharmaceuticals and its Subsidiaries Chapter 7

Last in line are the company’s stockholders. They take the greatest amount of risk in the success or failure of a company. Thus, their recovery is limited by the preferential claims of secured and unsecured creditors. Stockholders cannot recover any assets if the secured and unsecured creditors’ claims are not fully repaid.

Unlike an individual debtor, a non-individual debtor does not achieve a discharge of its debts following liquidation; discharge of liability is only available to individual debtors (see 11 U.S. Code § 727).

After the trustee a final report and the trustee is discharged from his position by the judge immune pharmaceuticals will be a shell company with no officers or directors just liabilities.

Shares of Immune Pharmaceuticals WORTHLESS

Cheers
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.